Small, mostly single-dose or open-label studies at 300 to 800 mg; pooled results are inconsistent and there is no good trial at 150 mg a day or less.
How we grade evidenceCBD is not a proven treatment for anxiety. A handful of small studies found lower anxiety scores with doses of 300 to 600 mg in a public-speaking test or over a few weeks, but when placebo-controlled trials are pooled the effect is not statistically significant. No good trial has tested the low doses most people have in mind.
What the research shows
The studies that reported an effect
- Social anxiety, single dose. In a 2011 study, 24 people with social anxiety disorder who had never been treated took a single 600 mg dose of CBD or a placebo before a simulated public-speaking test. Those given CBD had less anxiety during the speech.1
- Dose matters, in an odd way. A later public-speaking study found that 300 mg reduced anxiety compared with placebo, while both lower and higher doses did not. Researchers call this an inverted U-shaped dose response.2
- Four weeks in teenagers. A double-blind trial in Japan gave 37 teenagers aged 18 to 19 with social anxiety disorder either 300 mg of CBD (17 people) or placebo (20 people) each day for four weeks. Anxiety scores fell significantly more with CBD on both scales used.3
These were small studies. Two of the three tested a single dose in a laboratory setting, which is a long way from treating an anxiety disorder over months.
The Australian youth study
An Australian study gave CBD to 31 people aged 12 to 25 whose anxiety had not responded to standard treatment. The dose was increased up to 800 mg a day over 12 weeks. Self-rated anxiety scores fell by 42.6%, from 10.8 to 6.3.4
This study was open-label, which means there was no placebo group and everyone knew they were taking CBD. Anxiety responds strongly to expectation, and the authors themselves say a placebo effect cannot be ruled out.4 A placebo-controlled follow-up trial planned for 180 young people was still recruiting in November 2024. We found no published results as of November 2026.5
The pooled evidence
When reviewers gather all the trials, the picture is weaker.
- A 2024 systematic review found 15 randomised trials published from 2013 to 2023. In 9 of the 15 (60%), a single dose of CBD showed no benefit for anxiety.6
- A 2025 meta-analysis (a study that pools trials) covered 21 placebo-controlled trials, including trials in PTSD, obsessive-compulsive disorder and Tourette syndrome as well as anxiety disorders. Overall, the effect of pure or enriched CBD was not statistically significant, although a smaller subgroup of pure-CBD studies did reach significance. Only one of the 21 trials studied generalised anxiety disorder, the most common long-term form.7
- A 2026 review in The Lancet Psychiatry pooled 54 trials and 2,477 participants across all cannabinoids, including products with THC. It found no significant effect on anxiety outcomes and concluded that routine use of cannabinoids for mental disorders “is currently rarely justified”.8
- A 2025 double-blind trial of 150, 300 or 600 mg of CBD found no effect on fear and panic symptoms brought on by a carbon dioxide breathing test.9
See how we grade the evidence for why pooled, placebo-controlled results count for more than single small studies.
What doses were tested
The studies that reported an effect used 300 to 600 mg as a single dose, 300 mg a day for four weeks, or up to 800 mg a day.1234
For comparison, the Australian limit for pharmacist-only (Schedule 3) CBD is 150 mg a day.10 A review by Australian researchers found that the benefits of oral CBD “became more clearly evident at doses ≥300 mg”.11 No good trial has tested daily doses of 150 mg or less for an anxiety disorder, so the evidence above cannot be stretched to cover low-dose products. Our page on low-dose CBD goes into this.
What Australian medical bodies say
- RANZCP. The Royal Australian and New Zealand College of Psychiatrists updated its clinical memorandum in March 2024. It says there is insufficient evidence to support medicinal cannabis as a treatment for anxiety and other mental disorders, and raises concern about overprescribing.12
- RACGP. The Royal Australian College of General Practitioners calls the overall evidence base for medicinal cannabis “limited and inconclusive” and says it should only be considered after first-line, evidence-based treatments have been exhausted.13
The full picture is on our page about what Australian medical bodies say.
Risks to know about
- Side effects. In trials, the effects most often linked to CBD were diarrhoea and sleepiness.14 See CBD side effects.
- Liver enzymes at trial doses. In a study of healthy adults taking about 350 to 400 mg a day for four weeks, 5.6% had liver enzymes rise to more than three times the normal upper limit. None had symptoms, and levels returned to normal after stopping.15 That dose sits within the range used in anxiety studies. See CBD and the liver.
- Other medicines. CBD blocks several liver enzymes that break down other medicines, and it adds to the sedation from benzodiazepines, other sedatives and alcohol.16 In six participants in the Australian youth anxiety study who were also taking the antidepressants citalopram or escitalopram, citalopram blood levels rose after CBD was added. Whether that caused more side effects was not established.17 If you take any medicine for anxiety or depression, check CBD drug interactions and ask your pharmacist.
- THC is different. Some products prescribed for anxiety contain THC as well as CBD. In an Australian cancer trial, short-lived anxiety was reported more often with THC:CBD capsules (which contain THC) than with placebo, 4% against 1%.18 Check what a product contains. See CBD vs THC.
If you are considering it
- Start with your GP. Ask what the first-line treatments are for your type of anxiety and whether you have tried them properly. Our guide to talking to your GP about CBD may help.
- Bring a full list of your medicines and supplements.
- Questions worth asking about any treatment suggested: What evidence is there at the dose proposed? Does the product contain any THC? What are the risks and interactions with my other medicines? How will we measure whether it is working, and when would we stop?
Footnotes
-
Bergamaschi MM, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology, 2011. https://pubmed.ncbi.nlm.nih.gov/21307846/ ↩ ↩2
-
Linares IM, et al. Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test, 2019. https://pmc.ncbi.nlm.nih.gov/articles/PMC6781714/ ↩ ↩2
-
Masataka N. Anxiolytic effects of repeated cannabidiol treatment in teenagers with social anxiety disorders. Frontiers in Psychology, 2019. https://www.frontiersin.org/articles/10.3389/fpsyg.2019.02466/full ↩ ↩2
-
Berger M, et al. Cannabidiol for treatment-resistant anxiety disorders in young people: an open-label trial. Journal of Clinical Psychiatry, 2022. https://pubmed.ncbi.nlm.nih.gov/35921510/ ↩ ↩2 ↩3
-
Orygen. CANCAN study: frequently asked questions for clinicians, November 2024. https://www.orygen.org.au/Research/Currently-recruiting/CANCAN-study/CANCAN-FAQ-CLINICIANS-November-2024.aspx ↩
-
Systematic review of randomised controlled trials of cannabidiol for anxiety, 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11595441/ ↩
-
Meta-analysis of placebo-controlled trials of cannabidiol for anxiety. Cannabis and Cannabinoid Research, 2025. https://pubmed.ncbi.nlm.nih.gov/40956670/ ↩
-
Wilson J, et al. Cannabinoids for mental disorders: systematic review and meta-analysis. The Lancet Psychiatry, 2026. https://pubmed.ncbi.nlm.nih.gov/41856154/ ↩
-
PsyPost. Report of a 2025 double-blind trial of cannabidiol and carbon dioxide induced fear and panic. https://psypost.org/cannabidiol-has-no-effect-on-fear-and-panic-symptoms-study-finds ↩
-
Therapeutic Goods Administration. Final decision on down-scheduling of low-dose cannabidiol, 2020. https://tga.gov.au/node/284859 ↩
-
Arnold JC, McCartney D, Suraev A, McGregor IS. The safety and efficacy of low oral doses of cannabidiol. Clinical and Translational Science, 2023. https://pubmed.ncbi.nlm.nih.gov/36259271/ ↩
-
Royal Australian and New Zealand College of Psychiatrists. Updated clinical memorandum: therapeutic use of medicinal cannabis, March 2024. https://ranzcp.org/news-analysis/updated-clinical-memorandum-therapeutic-use-of-medicinal-cannabis ↩
-
Royal Australian College of General Practitioners. Position statement: use of medicinal cannabis products in Australia (2019 update). https://www.racgp.org.au/advocacy/position-statements/view-all-position-statements/clinical-and-practice-management/medical-cannabis ↩
-
Chesney E, et al. Adverse effects of cannabidiol: a systematic review and meta-analysis of randomised clinical trials, 2020. https://pubmed.ncbi.nlm.nih.gov/32268347/ ↩
-
EurekAlert. News release on Florian et al., cannabidiol and liver enzyme elevations in healthy adults, JAMA Internal Medicine, July 2025. https://www.eurekalert.org/news-releases/1089832 ↩
-
US National Library of Medicine, DailyMed. Epidiolex (cannabidiol) oral solution prescribing information, revised 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bf27097-4870-43fb-94f0-f3d0871d1eec ↩
-
Anderson LL and others. Citalopram and cannabidiol: in vitro and in vivo evidence of pharmacokinetic interactions relevant to the treatment of anxiety disorders in young people. Journal of Clinical Psychopharmacology, 2021. https://doi.org/10.1097/JCP.0000000000001427 ↩
-
The ASCO Post. Oral cannabis extract for refractory chemotherapy-induced nausea and vomiting (report of Grimison et al., Journal of Clinical Oncology, 2024). https://ascopost.com/news/august-2024/oral-cannabis-extract-for-refractory-chemotherapy-induced-nausea-and-vomiting/ ↩
Common questions
Does CBD oil help anxiety?
It is not proven. A few small studies using 300 to 600 mg found less anxiety than placebo, but a 2025 analysis pooling 21 placebo-controlled trials found the overall effect was not statistically significant. Larger and longer trials are needed.
How much CBD was used in anxiety studies?
Most studies used single doses of 300 to 600 mg, and one Australian study in young people went up to 800 mg a day. These are much higher than the 150 mg a day limit for pharmacist-only CBD in Australia. There is no good trial showing that low doses reduce anxiety.
Is CBD better than antidepressants or therapy for anxiety?
No trial has shown that. Psychological therapy and some prescription medicines have far more evidence behind them. The RACGP says medicinal cannabis should only be considered after first-line, evidence-based treatments have been tried.
Can I take CBD with my anxiety medication?
Ask your doctor or pharmacist first. CBD affects liver enzymes that break down many medicines, and it adds to the drowsiness caused by sedatives such as benzodiazepines and by alcohol.
This page is general information, not medical or legal advice. Laws and evidence change; we show the date we last checked the facts at the top of every page. Talk to your doctor or pharmacist before starting, stopping or changing any medicine.
Didn't find what you needed? Ask us a question.
Get the monthly update
One short email a month: what changed in Australian CBD law, regulation and research, and which guides we updated. No advertising. Unsubscribe any time. (As of November 2026 we are collecting sign-ups; the first update has not been sent yet.)